Cancer Therapy Market Developments And Opportunities Across 2026–2030

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Does The Market Size Of The Cancer Therapy Market Compare Between 2026 And 2030?

The cancer therapy market size has expanded significantly in recent years. It is projected to increase from $210.44 billion in 2025 to $232.47 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.5%. Historically, this growth can be attributed to factors such as rising cancer incidence, chemotherapy adoption, hospital oncology infrastructure, radiation therapy expansion, and an aging population.

The cancer therapy market is projected to experience substantial expansion in the coming years. This market is anticipated to reach $342.1 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.1%. Factors contributing to this growth during the projected timeframe include the development of biomarker-driven therapies, an expanding immuno-oncology pipeline, increased uptake of precision medicine, escalating healthcare spending, and improved early cancer detection methods. Key developments expected in the forecast period encompass the swift embrace of immunotherapy, the proliferation of targeted cancer treatments, the broadening scope of precision oncology, a rise in the application of combination therapies, and a move towards tailored treatment regimens.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24492&type=smp

What Significant Factors Are Influencing The Cancer Therapy Market Expansion?

The future expansion of the cancer therapy market is anticipated to be driven by the rising incidence of cancer. Cancer is defined as a collection of illnesses marked by the unregulated multiplication and dissemination of atypical cells throughout the body. The primary reason for the rise in cancer cases is heightened exposure to environmental carcinogens, including pollution and tobacco smoke. Cancer therapy is vital for addressing the growing prevalence of cancer through managing existing cases, enhancing patient survival, and slowing down disease advancement. As an illustration, data from February 2024 provided by the World Health Organization (WHO), an intergovernmental organization located in Switzerland, projects that worldwide cancer incidence will surpass 35 million new cases by the year 2050. This signifies a 77% surge compared to the approximately 20 million cases documented in 2022. Consequently, the growing occurrence of cancer is a key factor propelling the cancer therapy market.

How Is The Cancer Therapy Market Categorized Across Its Segment Groups?

The cancer therapy market covered in this report is segmented –

1) By Therapy Type: Chemotherapy, Target Therapy, Immunotherapy, Radiotherapy, Other Therapy Types

2) By Cancer Type: Blood Cancer, Breast Cancer, Prostate Cancer, Gastrointestinal Cancer, Gynaecologic Cancer, Respiratory Or Lung Cancer, Other Cancer Types

3) By End User: Hospitals, Specialty Clinics, Cancer And Radiation Therapy Centers

Subsegments:

1) By Chemotherapy: Alkylating Agents, Antimetabolites, Anti-Tumor Antibiotics, Topoisomerase Inhibitors, Mitotic Inhibitors, Corticosteroids, Other Chemotherapy Drugs

2) By Targeted Therapy: Monoclonal Antibodies, Tyrosine Kinase Inhibitors (TKIs), mTOR Inhibitors, Proteasome Inhibitors, PARP Inhibitors, Other Targeted Agents

3) By Immunotherapy: Immune Checkpoint Inhibitors, CAR T-cell Therapy, Cancer Vaccines, Cytokines, Oncolytic Virus Therapy, Other Immunotherapies

4) By Radiotherapy: External Beam Radiation Therapy (EBRT), Internal Radiation Therapy (Brachytherapy), Systemic Radiation Therapy, Stereotactic Radiosurgery (SRS), Intensity-Modulated Radiation Therapy (IMRT), Image-Guided Radiation Therapy (IGRT)

5) By Other Therapy Types: Hormone Therapy, Stem Cell Transplant, Photodynamic Therapy, Cryoablation, Hyperthermia Therapy

Which Trends Are Impacting The Progress Of The Cancer Therapy Market?

Leading firms within the cancer therapy market are prioritizing the creation of advanced treatments, particularly immuno-oncology drugs, with the aim of boosting treatment efficacy by leveraging the body’s own immune defenses to identify and eliminate cancerous cells. These immuno-oncology medications represent a category of cancer therapies designed to activate or bolster the body’s intrinsic immune response for more efficient recognition and targeting of cancer cells. As an illustration, in December 2024, Dr. Reddy’s Laboratories Ltd., an India-based pharmaceutical firm, launched Toripalimab in India, marking it as the initial and sole immuno-oncology drug approved for addressing nasopharyngeal cancer. This introduction provides a novel, precise therapeutic alternative for individuals afflicted by this uncommon and severe cancer, holding the potential to better patient results via sophisticated immune system interaction. The availability of toripalimab in India highlights Dr. Reddy’s dedication to broadening access to state-of-the-art cancer treatments in regions with limited options.

Which Firms Are Influencing Competition In The Cancer Therapy Market?

Major companies operating in the cancer therapy market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Merck & Co. Inc., Bayer Aktiengesellschaft, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis International AG, GlaxoSmithKline PLC, Elekta AB, Exelixis Inc., Accuray Incorporated, Akeso Inc., Nanobiotix S.A., SOTIO Biotech a.s., AdvanCell Isotopes Pty Ltd, Axcynsis Therapeutics Pte Ltd, Clarity Pharmaceuticals Ltd, Affimed N.V., Aptadel Therapeutics S.L.

Get The Full Cancer Therapy Market Report:

https://www.thebusinessresearchcompany.com/report/cancer-therapy-global-market-report

Which Region Leads The Cancer Therapy Market In Overall Market Size?

North America was the largest region in the cancer therapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Cancer Therapy Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/cancer-therapy-global-market-report

Browse Through More Reports Similar to the Global Cancer Therapy Market 2026, By The Business Research Company

Oncology Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/oncology-drugs-global-market-report

Blood Cancer Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/blood-cancer-drugs-global-market-report

Cancer Immunotherapy Drug Discovery Outsourcing Market Report 2026

https://www.thebusinessresearchcompany.com/report/cancer-immunotherapy-drug-discovery-outsourcing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795